Medikit Co.,Ltd.

TSE:7749 Stock Report

Market Cap: JP¥40.0b

MedikitLtd Management

Management criteria checks 2/4

MedikitLtd's CEO is Yoji Kageyama, appointed in Jun 2021, has a tenure of 3.58 years. directly owns 0.14% of the company’s shares, worth ¥57.82M. The average tenure of the management team and the board of directors is 4.6 years and 9.6 years respectively.

Key information

Yoji Kageyama

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownership0.1%
Management average tenure4.6yrs
Board average tenure9.6yrs

Recent management updates

Recent updates

Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Mar 12
Update: MedikitLtd (TYO:7749) Stock Gained 79% In The Last Five Years

Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Feb 22
Is MedikitLtd (TYO:7749) Likely To Turn Things Around?

Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Feb 02
Has Medikit Co.,Ltd. (TYO:7749) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Is Medikit Co.,Ltd. (TYO:7749) A Smart Choice For Dividend Investors?

Jan 13
Is Medikit Co.,Ltd. (TYO:7749) A Smart Choice For Dividend Investors?

Is Medikit Co.,Ltd.'s (TYO:7749) Shareholder Ownership Skewed Towards Insiders?

Dec 22
Is Medikit Co.,Ltd.'s (TYO:7749) Shareholder Ownership Skewed Towards Insiders?

Investors Who Bought MedikitLtd (TYO:7749) Shares Five Years Ago Are Now Up 80%

Dec 01
Investors Who Bought MedikitLtd (TYO:7749) Shares Five Years Ago Are Now Up 80%

CEO

Yoji Kageyama (64 yo)

3.6yrs

Tenure

Mr. Yoji Kageyama is President & Representative Director of Medikit Co.,Ltd. from June 2021. He joined the Medikit Co.,Ltd.in May 1986. He was MD of Sales Department, East Japan Overseas Business Division...

Leadership Team

NamePositionTenureCompensationOwnership
Hiroaki Nakajima
Founderno dataJP¥131.10mno data
Yoji Kageyama
President & Representative Director3.6yrsno data0.14%
¥ 57.8m
Takashi Nakajima
Executive VP of Administration Division & Director3.6yrsno data5.72%
¥ 2.3b
Hiroshi Horinouchi
Sales Administration Department & Director10.3yrsno data0.066%
¥ 26.5m
Fumihiro Nakajima
Director & Director of Corporate Planning5.6yrsno data0.022%
¥ 8.6m

4.6yrs

Average Tenure

64yo

Average Age

Experienced Management: 7749's management team is considered experienced (4.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yoji Kageyama
President & Representative Director15.6yrsno data0.14%
¥ 57.8m
Takashi Nakajima
Executive VP of Administration Division & Director14.6yrsno data5.72%
¥ 2.3b
Hiroshi Horinouchi
Sales Administration Department & Director9.6yrsno data0.066%
¥ 26.5m
Fumihiro Nakajima
Director & Director of Corporate Planning5.6yrsno data0.022%
¥ 8.6m
Yasuyuki Yoshida
Independent External Director9.6yrsno data0.0027%
¥ 1.1m
Shuji Oshima
External Auditor10.6yrsno datano data
Atsuko Otaki
Independent Outside Director3.6yrsno datano data
Fukuichi Yoshida
Outside Corporate Auditor3.6yrsno datano data
Naomichi Kaneko
Full Time Auditor7.6yrsno data0.054%
¥ 21.6m

9.6yrs

Average Tenure

64yo

Average Age

Experienced Board: 7749's board of directors are considered experienced (9.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 09:37
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medikit Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Takashi AkahaneTokai Tokyo Intelligence Laboratory Co., Ltd.